Quality is intricate part of our business

1100 quality experts

Consecutive 4 successful US FDA audits

With an objective to make affordable and accessible medication available, each MSN member has worked with high commitment and passion, helping us reach great heights. In a short span of 17 years, we recorded hundred percent growth over multiple years. We grew from zero in 2004 to USD 500 million in 2019. Apart from global accreditations and international regulatory standards, MSN has to its credit:

Excellence and consistency – our priorities every step of the way.

API Facilities Accreditations

FDF, R&D Facility Accreditations

Our ever-growing portfolio

We are extremely grateful for the wonderful family of clients and customers that we have built across the globe.